Kidney transplantation is considered to be the preferred treatment for patients with end stage kidney disease (ESRD). However, there is a critical shortage of transplantable organs, created by the ever-increasing prevalence of CKD and ESRD. At the end of 2025, more than 102,000 patients were waiting for a transplant (https://hrsa.unos.org/data/view-data-reports/national-data/#). During 2025, only 25,000 patients got a life-sustaining transplant, many having waited 3-5 years for kidney to become available. NIDDK estimates that 300 people with ESRD die every day while waiting for a kidney transplant. (https://usrds-adr.niddk.nih.gov/2023/end-stage-renal-disease/6-mortality)
RTI has harnessed its Rametrix® technology to help solve the problem of the shortfall of transplantable kidneys – providing more viable organs for transplants that will save lives.
Read On!